{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:37:00Z","timestamp":1790509020431,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["814244"],"award-info":[{"award-number":["814244"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RM118164289636F0"],"award-info":[{"award-number":["RM118164289636F0"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RM11916B839074A8"],"award-info":[{"award-number":["RM11916B839074A8"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RP11715C7C4DC57A"],"award-info":[{"award-number":["RP11715C7C4DC57A"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bone.2021.116270","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:54:18Z","timestamp":1638615258000},"page":"116270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Fibrous dysplasia animal models: A systematic review"],"prefix":"10.1016","volume":"155","author":[{"given":"Chelsea","family":"Hopkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Fernandez","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Riminucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bone.2021.116270_bb0005","first-page":"818","article-title":"The correlation of specific orthopaedic features of polyostotic fibrous dysplasia with functional outcome scores in children","volume":"88","author":"Leet","year":"2006","journal-title":"J. Bone Joint Surg. Am."},{"issue":"5","key":"10.1016\/j.bone.2021.116270_bb0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00223-019-00550-z","article-title":"Fibrous dysplasia of bone and McCune-albright syndrome: a bench to bedside review","volume":"104","author":"Hartley","year":"2019","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00223-017-0329-5","article-title":"Illness perceptions are associated with quality of life in patients with fibrous dysplasia","volume":"102","author":"Majoor","year":"2018","journal-title":"Calcif. Tissue Int."},{"issue":"9","key":"10.1016\/j.bone.2021.116270_bb0020","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1359\/jbmr.070511","article-title":"Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome","volume":"22","author":"Hart","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00198-007-0425-x","article-title":"Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions","volume":"19","author":"Kelly","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116270_bb0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neubiorev.2021.02.009","article-title":"Pain phenotypes in rare musculoskeletal and neuromuscular diseases","volume":"124","author":"Tucker-Bartley","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.bone.2021.116270_bb0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1750-1172-7-S1-S3","article-title":"Pathophysiology and medical treatment of pain in fibrous dysplasia of bone","volume":"7","author":"Chapurlat","year":"2012","journal-title":"Orphanet. J. Rare Dis."},{"issue":"3","key":"10.1016\/j.bone.2021.116270_bb0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bone.2005.04.026","article-title":"Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone","volume":"37","author":"Kelly","year":"2005","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2021.116270_bb0045","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s11999-013-3380-1","article-title":"Radiographic classification of coronal plane femoral deformities in polyostotic fibrous dysplasia","volume":"472","author":"Ippolito","year":"2014","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"Suppl 2","key":"10.1016\/j.bone.2021.116270_bb0050","doi-asserted-by":"crossref","first-page":"P120","DOI":"10.1359\/jbmr.06s223","article-title":"G(s)alpha mutations in fibrous dysplasia and McCune-albright syndrome","volume":"21","author":"Weinstein","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116270_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2106\/JBJS.O.00547","article-title":"Bone-grafting in polyostotic fibrous dysplasia","volume":"98","author":"Leet","year":"2016","journal-title":"J. Bone Joint Surg. Am."},{"issue":"4","key":"10.1016\/j.bone.2021.116270_bb0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/jbmr.3649","article-title":"Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone","volume":"34","author":"Florenzano","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2021.116270_bb0065","first-page":"1587","article-title":"Fibrous dysplasia of bone in the McCune-albright syndrome: abnormalities in bone formation","volume":"151","author":"Riminucci","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13023-019-1102-9","article-title":"Best practice management guidelines for fibrous dysplasia\/McCune-albright syndrome: a consensus statement from the FD\/MAS international consortium","volume":"14","author":"Javaid","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11832-007-0006-8","article-title":"Current approach to fibrous dysplasia of bone and McCune-albright syndrome","volume":"1","author":"Leet","year":"2007","journal-title":"J. Child. Orthop."},{"issue":"7","key":"10.1016\/j.bone.2021.116270_bb0080","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/jbmr.2003.18.7.1235","article-title":"Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations","volume":"18","author":"Corsi","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.berh.2007.11.004","article-title":"Fibrous dysplasia of bone and McCune-albright syndrome","volume":"22","author":"Chapurlat","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.bone.2021.116270_bb0090","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1210\/jc.2018-02543","article-title":"Denosumab in patients with fibrous dysplasia previously treated with bisphosphonates","volume":"104","author":"Majoor","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2021.116270_bb0095","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2021.116270_bb0100","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.4380","article-title":"Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-albright syndrome: an observational study","volume":"36","author":"Meier","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116270_bb0105","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fendo.2019.00925","article-title":"Advances in models of fibrous Dysplasia\/McCune-albright syndrome","volume":"10","author":"Lung","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.bone.2021.116270_bb0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jbmr.3602","article-title":"Activation of RANK\/RANKL\/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden","volume":"34","author":"de Castro","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.116270_bb0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1525-1578(10)60618-6","article-title":"A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues","volume":"2","author":"Sakamoto","year":"2000","journal-title":"J. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13023-017-0629-x","article-title":"Determinants of impaired quality of life in patients with fibrous dysplasia","volume":"12","author":"Majoor","year":"2017","journal-title":"Orphanet. J. Rare Dis."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5858\/arpa.2012.0013-RS","article-title":"Fibrous dysplasia","volume":"137","author":"Riddle","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.bone.2021.116270_bb0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/berh.1999.0071","article-title":"Fibrous dysplasia of bone, baillieres","volume":"14","author":"Chapurlat","year":"2000","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.bone.2021.116270_bb0135","first-page":"1848","article-title":"Fibrous dysplasia: pathophysiology, evaluation, and treatment","volume":"87","author":"DiCaprio","year":"2005","journal-title":"JBJS"},{"issue":"2","key":"10.1016\/j.bone.2021.116270_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J","article-title":"The histopathology of fibrous dysplasia of bone in patients with activating mutations of the gs alpha gene: site-specific patterns and recurrent histological hallmarks","volume":"187","author":"Riminucci","year":"1999","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.bone.2021.116270_bb0145","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2214\/ajr.182.6.1821389","article-title":"Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation","volume":"182","author":"Fitzpatrick","year":"2004","journal-title":"AJR Am. J. Roentgenol."},{"issue":"8","key":"10.1016\/j.bone.2021.116270_bb0150","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1359\/jbmr.1997.12.8.1314","article-title":"Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density","volume":"12","author":"Weinstein","year":"1997","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.116270_bb0155","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116270_bb0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/modpathol.3800753","article-title":"Ossifying fibroma vs fibrous dysplasia of the jaw: molecular and immunological characterization","volume":"20","author":"Toyosawa","year":"2007","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bone.2021.116270_bb0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2019.01.004","article-title":"Serum periostin levels and severity of fibrous dysplasia of bone","volume":"121","author":"Guerin Lemaire","year":"2019","journal-title":"Bone"},{"issue":"50","key":"10.1016\/j.bone.2021.116270_bb0170","doi-asserted-by":"crossref","first-page":"20101","DOI":"10.1073\/pnas.1114656108","article-title":"Wnt\/beta-catenin signaling is differentially regulated by galpha proteins and contributes to fibrous dysplasia","volume":"108","author":"Regard","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2021.116270_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"10.1016\/j.bone.2021.116270_bb0180","doi-asserted-by":"crossref","first-page":"E418","DOI":"10.1073\/pnas.1714313114","article-title":"Induced Gnas(R201H) expression from the endogenous gnas locus causes fibrous dysplasia by up-regulating Wnt\/beta-catenin signaling","volume":"115","author":"Khan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bone.2021.116270_bb0185","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jbmr.2425","article-title":"Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gs(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse","volume":"30","author":"Remoli","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2021.116270_bb0190","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/jbmr.2267","article-title":"Constitutive expression of Gsalpha(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history","volume":"29","author":"Saggio","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.116270_bb0195","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1359\/jbmr.091036","article-title":"Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors","volume":"25","author":"Piersanti","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116270_bb0200","doi-asserted-by":"crossref","first-page":"E428","DOI":"10.1073\/pnas.1713710115","article-title":"Expression of an active G alpha(s) mutant in skeletal stem cells is sufficient and necessary for fibrous dysplasia initiation and maintenance","volume":"115","author":"Zhao","year":"2018","journal-title":"<em>Proc<\/em><span>.<span\/><\/span><em>Natl<\/em><span>.<span\/><\/span><em>Acad<\/em><span>.<span\/><\/span><em>Sci<\/em><span>.<span\/><\/span><em>U.S.A.<\/em>"},{"issue":"6","key":"10.1016\/j.bone.2021.116270_bb0205","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ncb3164","article-title":"Inactivation of a Galpha(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis","volume":"17","author":"Iglesias-Bartolome","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"16","key":"10.1016\/j.bone.2021.116270_bb0210","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.02480","article-title":"Distinct roles for hedgehog and canonical wnt signaling in specification, differentiation and maintenance of osteoblast progenitors","volume":"133","author":"Rodda","year":"2006","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.bone.2021.116270_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/gene.10092","article-title":"Expression of cre recombinase in the developing mouse limb bud driven by a prxl enhancer","volume":"33","author":"Logan","year":"2002","journal-title":"Genesis"},{"issue":"44","key":"10.1016\/j.bone.2021.116270_bb0220","doi-asserted-by":"crossref","first-page":"38558","DOI":"10.1074\/jbc.M111.240150","article-title":"Extra-long galphas variant XLalphas protein escapes activation-induced subcellular redistribution and is able to provide sustained signaling","volume":"286","author":"Liu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2021.116270_bb0225","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bone.2018.02.016","article-title":"Constitutive stimulatory G protein activity in limb mesenchyme impairs bone growth","volume":"110","author":"Karaca","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116270_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-018-0034-7","article-title":"G alpha(s) signaling controls intramembranous ossification during cranial bone development by regulating both hedgehog and Wnt\/beta-catenin signaling","volume":"6","author":"Xu","year":"2018","journal-title":"Bone Res."},{"issue":"12","key":"10.1016\/j.bone.2021.116270_bb0235","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/jbmr.3828","article-title":"RANKL inhibition in fibrous dysplasia of bone: a preclinical study in a mouse model of the human disease","volume":"34","author":"Palmisano","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2021.116270_bb0240","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00223-020-00752-w","article-title":"Zoledronic acid in a mouse model of human fibrous dysplasia: ineffectiveness on tissue pathology, formation of \"giant osteoclasts\" and pathogenetic implications","volume":"107","author":"Corsi","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2021.116270_bb0245","doi-asserted-by":"crossref","first-page":"P125","DOI":"10.1359\/jbmr.06s224","article-title":"Fibrous dysplasia as a stem cell disease","volume":"21","author":"Riminucci","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.116270_bb0250","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ilar.47.2.94","article-title":"Mouse phenome research: implications of genetic background","volume":"47","author":"Yoshiki","year":"2006","journal-title":"ILAR J."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0255","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41467-019-09716-7","article-title":"Humanising the mouse genome piece by piece","volume":"10","author":"Zhu","year":"2019","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.bone.2021.116270_bb0260","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1182\/blood-2011-11-395418","article-title":"Activated gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice","volume":"120","author":"Schepers","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bone.2021.116270_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094989","article-title":"Disrupted bone remodeling leads to cochlear overgrowth and hearing loss in a mouse model of fibrous dysplasia","volume":"9","author":"Akil","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bone.2021.116270_bb0270","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/jbmr.3","article-title":"Gs G protein-coupled receptor signaling in osteoblasts elicits age-dependent effects on bone formation","volume":"25","author":"Hsiao","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116270_bb0275","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/me.2009-0424","article-title":"Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formation","volume":"24","author":"Hsiao","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00223-011-9487-z","article-title":"Mineral composition is altered by osteoblast expression of an engineered G(s)-coupled receptor","volume":"89","author":"Kazakia","year":"2011","journal-title":"Calcified Tissue Int."},{"issue":"4","key":"10.1016\/j.bone.2021.116270_bb0285","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1073\/pnas.0707457105","article-title":"Osteoblast expression of an engineered gs-coupled receptor dramatically increases bone mass","volume":"105","author":"Hsiao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0290","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1210\/en.2015-1614","article-title":"Activation of protein kinase a in mature osteoblasts promotes a major bone anabolic response","volume":"157","author":"Tascau","year":"2016","journal-title":"Endocrinology"},{"issue":"19","key":"10.1016\/j.bone.2021.116270_bb0295","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1073\/pnas.1003680107","article-title":"Alternate protein kinase a activity identifies a unique population of stromal cells in adult bone","volume":"107","author":"Tsang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2021.116270_bb0300","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mce.2016.08.004","article-title":"Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase a (PKA) defects","volume":"439","author":"Saloustros","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"21","key":"10.1016\/j.bone.2021.116270_bb0305","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1093\/hmg\/ddv320","article-title":"Haploinsufficiency for either one of the type-II regulatory subunits of protein kinase a improves the bone phenotype of Prkar1a(+\/-) mice","volume":"24","author":"Liu","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2021.116270_bb0310","first-page":"235","article-title":"Mechanisms of protein kinase a anchoring","author":"Skroblin","year":"2010","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.bone.2021.116270_bb0315","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00000478-200102000-00004","article-title":"Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders","volume":"25","author":"Carney","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.bone.2021.116270_bb0320","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0042-117111","article-title":"Bone abnormalities in mice with protein kinase a (PKA) defects reveal a role of cyclic AMP signaling in bone stromal cell-dependent tumor development","volume":"48","author":"Liu","year":"2016","journal-title":"Horm. Metab. Res."},{"issue":"11","key":"10.1016\/j.bone.2021.116270_bb0325","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1530\/ERC-20-0309","article-title":"PRKACB variants in skeletal disease or adrenocortical hyperplasia: effects on protein kinase a","volume":"27","author":"Espiard","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.bone.2021.116270_bb0330","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1172\/JCI11296","article-title":"Activated parathyroid hormone\/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone","volume":"107","author":"Calvi","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bone.2021.116270_bb0335","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1083\/jcb.200408079","article-title":"The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH\/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow","volume":"167","author":"Kuznetsov","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2021.116270_bb0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-386035-4.00002-1","article-title":"New insights into the mechanism of wnt signaling pathway activation","volume":"291","author":"Kikuchi","year":"2011","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.bone.2021.116270_bb0345","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bone.2015.12.003","article-title":"Bone marrow fibrosis with fibrocytic and immunoregulatory responses induced by beta-catenin activation in osteoprogenitors","volume":"84","author":"Yu","year":"2016","journal-title":"Bone"},{"issue":"50","key":"10.1016\/j.bone.2021.116270_bb0350","doi-asserted-by":"crossref","first-page":"20101","DOI":"10.1073\/pnas.1114656108","article-title":"Wnt\/beta-catenin signaling is differentially regulated by G alpha proteins and contributes to fibrous dysplasia","volume":"108","author":"Regard","year":"2011","journal-title":"<em>Proc<\/em><span>.<span\/><\/span><em>Natl<\/em><span>.<span\/><\/span><em>Acad<\/em><span>.<span\/><\/span><em>Sci<\/em><span>.<span\/><\/span><em>U.S.A.<\/em>"},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0355","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0167-4781(93)90243-7","article-title":"The c-fos cAMP-response element: regulation of gene expression by a beta 2-adrenergic agonist, serum and DNA methylation","volume":"1173","author":"Moens","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"23","key":"10.1016\/j.bone.2021.116270_bb0360","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJM199506083322304","article-title":"Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia","volume":"332","author":"Candeliere","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"6103","key":"10.1016\/j.bone.2021.116270_bb0365","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/325412a0","article-title":"Deregulated C-fos expression interferes with Normal bone-development in transgenic mice","volume":"325","author":"Ruther","year":"1987","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bone.2021.116270_bb0370","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.humpath.2008.07.008","article-title":"Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-fos-overexpressing bone lesions","volume":"40","author":"Kashimaa","year":"2009","journal-title":"Hum. Pathol."},{"issue":"11","key":"10.1016\/j.bone.2021.116270_bb0375","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1359\/jbmr.080609","article-title":"Age-dependent demise of GNAS-mutated skeletal stem cells and \"normalization\" of fibrous dysplasia of bone","volume":"23","author":"Kuznetsov","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116270_bb0380","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/path.4033","article-title":"The CREB-Smad6-Runx2 axis contributes to the impaired osteogenesis potential of bone marrow stromal cells in fibrous dysplasia of bone","volume":"228","author":"Fan","year":"2012","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.bone.2021.116270_bb0385","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1359\/jbmr.2001.16.9.1710","article-title":"Gnathodiaphyseal dysplasia: a syndrome of fibro-osseous lesions of jawbones, bone fragility, and long bone bowing","volume":"16","author":"Riminucci","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.116270_bb0390","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/sctm.18-0057","article-title":"HDAC8, a potential therapeutic target, regulates proliferation and differentiation of bone marrow stromal cells in fibrous dysplasia","volume":"8","author":"Xiao","year":"2019","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"10.1016\/j.bone.2021.116270_bb0395","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1172\/JCI2361","article-title":"Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and gsalpha-mutated skeletal progenitor cells","volume":"101","author":"Bianco","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.bone.2021.116270_bb0400","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1073\/pnas.91.22.10488","article-title":"Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice","volume":"91","author":"Michiels","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.bone.2021.116270_bb0405","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc1808583","article-title":"Mosaic effects of growth hormone on fibrous dysplasia of bone","volume":"379","author":"Roszko","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2021.116270_bb0410","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1210\/jc.2001-012022","article-title":"Characterization of gsp-mediated growth hormone excess in the context of McCune-albright syndrome","volume":"87","author":"Akintoye","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6 Pt 1","key":"10.1016\/j.bone.2021.116270_bb0415","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-3476(75)80952-8","article-title":"Editorial: albright syndrome: is it coming of age?","volume":"87","author":"Di George","year":"1975","journal-title":"J. Pediatr."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:44:18Z","timestamp":1762659858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221004361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":83,"alternative-id":["S8756328221004361"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116270","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrous dysplasia animal models: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116270"}}